Soligenix, Inc. (SNGX)

1.10 -0.01 (-0.90%) USD  |  NASDAQ  |  Feb 20, 16:00
1.09 -0.01 (-0.91%) Pre-Market: 20:00
More

Soligenix Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for SNGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Amgen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Merck & Co., Inc. Upgrade
Tonix Pharmaceuticals Holding Corp. Upgrade